Target intelligence / Profile preview

Cellular uptake machinery for exosomes

Molecular classification
Receptor, Transporter, Other
01

Overview

The cellular uptake machinery for exosomes refers to the collective set of receptors and endocytic pathways that facilitate the internalization of extracellular vesicles (EVs) by recipient cells. This machinery is not a single molecular entity but involves multiple mechanisms, including clathrin-mediated endocytosis, caveolin-dependent endocytosis, macropinocytosis, and phagocytosis (Mulcahy et al., 2014). Internalization is often initiated by the interaction between exosomal surface proteins (such as tetraspanins or integrins) and recipient cell surface molecules like heparan sulfate proteoglycans (HSPGs) (Christianson et al., 2013). Once internalized, exosomes release their molecular cargo—including proteins, lipids, and various RNA species—into the recipient cell, thereby modulating its physiological or pathological state. In the context of disease, this machinery is exploited by cancer cells to promote metastasis and by pathogens to facilitate viral entry or the spread of neurotoxic proteins (Hoshino et al., 2015). Therapeutic strategies targeting this machinery aim to disrupt these communication channels, although the lack of specificity for exosome-specific uptake versus general endocytosis remains a significant challenge for drug development.

Other names
Exosome internalization pathwaysExtracellular vesicle uptake machineryEV endocytic machinery
02

Mechanism of action

Inhibition of exosome-cell surface binding and disruption of endocytic internalization pathways

03

Biological functions

EndocytosisIntercellular communicationSignal transductionVesicle-mediated transport
04

Disease associations

CancerNeurodegenerative diseaseInfectionInflammation
05

Safety considerations

Non-specific inhibition of general endocytosisSystemic toxicityInterference with physiological intercellular communicationDisruption of essential nutrient uptake
06

Interacting drugs

Heparin

5 more in the full profile.

07

Biomarkers

CD63CD81CD9Heparan sulfate proteoglycan expressionIntegrin alpha-V beta-5Glypican-1

Beyond the preview

Go deeper on Cellular uptake machinery for exosomes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular uptake machinery for exosomes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call